An escalating Ebola crisis in Congo reveals the virus is rapidly spreading, with the response effort only just beginning to take shape.
A groundbreaking scientific development suggests a single dose of an experimental gene-editing drug could offer long-term prevention for heart disease by reducing LDL cholesterol.